These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6180128)

  • 21. Enzymatic modifications of human fibroblast and leukocyte interferons.
    Otto MJ; Sedmak JJ; Grossberg SE
    J Virol; 1980 Aug; 35(2):390-9. PubMed ID: 6160260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radioimmunoassay of human beta interferon.
    Neurath AR; Strick N; Raj NB; Pitha PM
    J Interferon Res; 1982; 2(1):51-7. PubMed ID: 6180106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence that desialylation and uptake by hepatic receptors for galactose-terminated glycoproteins are immaterial to the metabolism of human choriogonadotropin in the rat.
    Lefort GP; Stolk JM; Nisula BC
    Endocrinology; 1984 Oct; 115(4):1551-7. PubMed ID: 6207012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endogenous levels of mRNA for IFNs and IFN-related genes in hepatic biopsies of chronic HCV-infected and non-alcoholic steatohepatitis patients.
    Abbate I; Romano M; Longo R; Cappiello G; Lo Iacono O; Di Marco V; Paparella C; Spano A; Capobianchi MR
    J Med Virol; 2003 Aug; 70(4):581-7. PubMed ID: 12794720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding of drugs to alpha 1-acid glycoprotein and its desialylated form. Influence on hepatic disposition and implications for drug targeting to the liver.
    Meijer DK; van der Sluijs P
    Prog Clin Biol Res; 1989; 300():143-67. PubMed ID: 2674961
    [No Abstract]   [Full Text] [Related]  

  • 26. Physiological ageing of red blood cells and changes in membrane carbohydrates.
    Gattegno L; Fabia F; Bladier D; Cornillot P
    Biomedicine; 1979 Oct; 30(4):194-9. PubMed ID: 534673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The kidney is the main site of interferon catabolism.
    Bocci V; Pacini A; Muscettola M; Pessina GP; Paulesu L; Bandinelli L
    J Interferon Res; 1982; 2(2):309-14. PubMed ID: 7119511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. INTERFERON-LIKE ACTIVITY OF EXTRACTS OF HUMAN SPLEEN.
    MACKENZIE I
    Can Med Assoc J; 1965 Jul; 93(5):204-10. PubMed ID: 14323664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Some species of human leukocyte interferon are glycosylated.
    Labdon JE; Gibson KD; Sun S; Pestka S
    Arch Biochem Biophys; 1984 Jul; 232(1):422-6. PubMed ID: 6588921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of the kidney in catabolism of human leukocyte interferon.
    Bino T; Edery H; Gertler A; Rosenberg H
    J Gen Virol; 1982 Mar; 59(Pt 1):39-45. PubMed ID: 6175730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant human interferons.
    Otto B
    Arzneimittelforschung; 1985; 35(11):1750-2. PubMed ID: 2418848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Purification and partial characterization of pas-positive inclusion bodies from the liver in alpha 1-antitrypsin deficiency.
    Eriksson S; Larsson C
    N Engl J Med; 1975 Jan; 292(4):176-80. PubMed ID: 45843
    [No Abstract]   [Full Text] [Related]  

  • 33. The dual role of sialic acid in the hepatic recognition and catabolism of serum glycoproteins.
    Ashwell G; Morell A
    Biochem Soc Symp; 1974; (40):117-24. PubMed ID: 4620379
    [No Abstract]   [Full Text] [Related]  

  • 34. Interferons: chemical properties.
    Fantes KH
    Tex Rep Biol Med; 1977; 35():173-80. PubMed ID: 358445
    [No Abstract]   [Full Text] [Related]  

  • 35. Chemical modification of the recombinant human alpha A- and beta-interferons.
    Borukhov SI; Strongin AYa
    Biochem Biophys Res Commun; 1990 Feb; 167(1):74-80. PubMed ID: 2106887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Catabolism of interferons.
    Bocci V
    Surv Immunol Res; 1982; 1(2):137-43. PubMed ID: 6195713
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacokinetics of interferons. A reappraisal.
    Bocci V
    Tex Rep Biol Med; 1981-1982; 41():336-43. PubMed ID: 6184823
    [No Abstract]   [Full Text] [Related]  

  • 38. Interferons: chemical properties.
    Fantes KH
    Tex Rep Biol Med; 1981-1982; 41():240-9. PubMed ID: 6184810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation of neuraminidase-resistant human alpha 1-protease inhibitor and its clearance in rat blood circulation.
    Omichi K; Savic G; Yoshida A
    Int J Biochem; 1983; 15(11):1345-51. PubMed ID: 6315502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolism of interferon (facts and fancy).
    Bocci V; Pacini A; Pessina GP; Bargigli V
    Ric Clin Lab; 1978; 8(1-2):17-25. PubMed ID: 705176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.